LifeSci Biotechnology Products Index
Effective at the market close on February 5, 2025, DVAX will be removed from the LifeSci Biotechnology Products Index and its value will be redistributed to the remaining index components based on their weights.
On December 24, 2025, Dynavax Technologies announced it would be acquired by Sanofi for $15.50/share in cash.